1,667 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Friday’s Close
MRK Merck & Company, Inc. $70.42 $187.28B Downtrend
Article Searches
Aurinia's CEO Glickman Spills Tidbits For 2019 https://seekingalpha.com/article/4234673-aurinias-ceo-glickman-spills-tidbits-2019?source=feed_sector_healthcare Jan 22, 2019 -
The Zacks Analyst Blog Highlights: Bank of America, Merck, Netflix, IBM and The Bank of New York Mellon http://www.zacks.com/stock/news/348753/the-zacks-analyst-blog-highlights-bank-of-america-merck-netflix-ibm-and-the-bank-of-new-york-mellon?cid=CS-ZC-FT-348753 Jan 22, 2019 - The Zacks Analyst Blog Highlights: Bank of America, Merck, Netflix, IBM and The Bank of New York Mellon
Merck's Partner Gets FDA Nod for Herceptin Biosimilar http://www.zacks.com/stock/news/348729/mercks-partner-gets-fda-nod-for-herceptin-biosimilar?cid=CS-ZC-FT-348729 Jan 21, 2019 - Merck's (MRK) partner, Samsung Bioepis Co. gets FDA approval for Ontruzant, a Herceptin Biosimilar.
Top Analyst Reports for Bank of America, Merck & Netflix http://www.zacks.com/research-daily/206820/top-analyst-reports-for-bank-of-america-merck-netflix?cid=CS-ZC-FT-206820 Jan 21, 2019 - Top Analyst Reports for Bank of America, Merck & Netflix
Don't Buy Codexis For The Long Haul https://seekingalpha.com/article/4234266-buy-codexis-long-haul?source=feed_sector_healthcare Jan 18, 2019 - CDX-6114's success in Phase 1a trials corresponded to a stock price bump. Short-term traders have future CDX-6114 results as upside potential.Partnerships and revenue streams will keep CDXS's stock af
The Week That Was In San Francisco: 2019 Should Be A Great Year For Healthcare Stocks https://seekingalpha.com/article/4234239-week-san-francisco-2019-great-year-healthcare-stocks?source=feed_all_articles Jan 18, 2019 -
Aerie's (AERI) Eye Care Candidate to Enter Clinical Studies http://www.zacks.com/stock/news/348354/aeries-aeri-eye-care-candidate-to-enter-clinical-studies?cid=CS-ZC-FT-348354 Jan 18, 2019 - Aerie's (AERI) Investigational New Drug Application for AR-1105 for the treatment of macular edema due to retinal vein occlusion is accepted by the FDA. The candidate will now enter clinical studies.
Dow 30 Stock Roundup: JPM & AXP Earnings Disappoint, GS & UNH Impress http://www.zacks.com/stock/news/348304/dow-30-stock-roundup-jpm-axp-earnings-disappoint-gs-unh-impress?cid=CS-ZC-FT-348304 Jan 18, 2019 - The index enjoyed another strong week of gains, increasing over three straight sessions.
Roche's sBLA for Tecentriq-Abraxane Combo Accepted by FDA http://www.zacks.com/stock/news/348232/roches-sbla-for-tecentriq-abraxane-combo-accepted-by-fda?cid=CS-ZC-FT-348232 Jan 17, 2019 - Roche's (RHHBY) sBLA for the label expansion of Tecentriq in combination with Abraxane for the initial treatment of NSCLC has been accepted by the FDA.
Stock Market News For Jan 15, 2019 http://www.zacks.com/stock/news/347445/stock-market-news-for-jan-15-2019?cid=CS-ZC--347445 Jan 15, 2019 - Benchmarks ended in the red on Monday as corporate earnings kicked off.

Pages: 123456...167

Page 1>

Related Companies

Name Exchange Price Mkt Cap
NVS Novartis AG NYSE $85.13 $197.65B
ABBV AbbVie Inc. NYSE $95.37 $144.42B
PFE Pfizer, Inc. NYSE $43.01 $252.13B
ABT Abbott Laboratories NYSE $67.67 $118.71B
NVO Novo Nordisk A/S NYSE $47.64 $114.84B
Sector: Health Care > Industry: Major Pharmaceuticals
DeepLinks for Merck & Company
MRK - Google Finance https://www.google.com/finance?q=MRK Industry related info and international coverage Summary News
MRK - Bloomberg http://www.bloomberg.com/research/stocks/snapshot/snapshot.asp?ticker=MRK Original news and commentary from Bloomberg Charts Financials with pensions Snapshot Earnings Transactions People Options